Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Janssen Pharmaceutical Cos.

Division of Johnson & Johnson
www.janssen.com

Latest From Janssen Pharmaceutical Cos.

Yet Another Myeloma CAR-T Therapy Makes It Onto EMA’s PRIME

Only two of seven applications for entry into the European Medicines Agency’s priority medicines scheme for getting treatments for unmet medical need to patients faster were successful last month.

Research and Development Strategies Europe

EU Accelerated Assessment Tracker

Roche has secured accelerated assessment at the European Medicines Agency for its new immunosuppressant, satralizumab. The outcomes of five other fast-track requests that companies have made for their planned marketing authorization applications are still unknown.

Europe European Performance Tracker

Keeping Track: US FDA, Industry Roar Into Fourth Quarter With Bevy Of Regulatory Announcements

The latest drug development news and highlights from our US FDA Performance Tracker.

US FDA Performance Tracker Approvals

Novartis Ramps Up Digital Transformation With Microsoft AI Deal

New five-year deal shows convergence of big pharma and big tech continues  though both sectors are wary of hype surrounding AI and digital health.

 

Artificial Intelligence Clinical Trials
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register